WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2022)
Top biotech stocks in 2022 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Consensus
Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
ITOS
ITEOS THERAPEUTICS INC
$722.18M$20.30$56.50178.33%Buy2-49.74%N/A-41.17%-33.57%
MRNA
MODERNA INC
$70.96B$184.70$180.50-2.27%Buy10-36.43%N/A22.44%15.50%
VIR
VIR BIOTECHNOLOGY INC
$3.43B$25.80$49.6092.25%Hold5-42.48%N/A-6.19%-4.94%
GMAB
GENMAB A
$30.18B$45.84$38.15-16.78%Hold721.18%11.83%4.48%3.89%
INCY
INCYTE CORP
$18.71B$84.11$75.83-9.84%Hold711.10%11.43%40.69%31.21%
TECH
BIO-TECHNE CORP
$12.86B$81.95$399.00386.88%Buy614.14%81.18%97.88%72.92%
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$3.55B$59.84$62.714.80%Strong Buy724.45%13.77%86.94%46.46%
CPRX
CATALYST PHARMACEUTICALS INC
$1.75B$16.80$16.830.20%Buy310.60%12.82%37.77%30.62%
PBYI
PUMA BIOTECHNOLOGY INC
$209.03M$4.58$8.0074.67%Buy19.91%38.28%115.36%12.86%
EXEL
EXELIXIS INC
$5.33B$16.52$27.5066.46%Buy69.99%18.76%26.28%22.11%
UTHR
UNITED THERAPEUTICS CORP
$12.76B$279.88$277.80-0.74%Buy117.75%7.66%23.17%18.28%
NBIX
NEUROCRINE BIOSCIENCES INC
$11.57B$120.39$120.810.35%Buy1612.49%109.21%46.31%33.37%
CSBR
CHAMPIONS ONCOLOGY INC
$89.79M$6.64$15.00125.90%Strong Buy215.85%287.30%67.74%17.69%
SIGA
SIGA TECHNOLOGIES INC
$585.65M$8.02N/AN/AN/AN/A-24.34%-31.52%30.37%25.74%
LPCN
LIPOCINE INC
$35.94M$0.41$3.33720.94%Strong Buy25.63%N/A21.16%20.21%
XOMA
XOMA CORP
$219.51M$19.17$62.50226.03%Strong Buy3-3.00%-5.39%22.58%20.14%
KNSA
KINIKSA PHARMACEUTICALS LTD
$1.06B$15.24$34.00123.10%Strong Buy122.75%N/A-16.12%-13.45%
CMRX
CHIMERIX INC
$194.58M$2.21$9.00307.24%Buy226.52%N/A-27.64%-25.77%
CDMO
AVID BIOSERVICES INC
$785.72M$12.61$24.0090.33%Strong Buy224.13%-30.27%24.07%9.87%
AUPH
AURINIA PHARMACEUTICALS INC
$653.70M$4.60$15.25231.52%Buy544.25%N/A42.62%36.96%
APVO
APTEVO THERAPEUTICS INC
$17.72M$3.48$20.00474.71%Strong Buy1-54.09%N/A-226.45%-112.61%
REGN
REGENERON PHARMACEUTICALS INC
$83.36B$765.42$770.160.62%Buy20-1.71%-6.83%21.17%16.40%
HUMA
HUMACYTE INC
$316.57M$3.07$10.00225.73%Strong Buy1161.22%N/A-99.06%-51.97%
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
$3.39B$13.30$23.8379.20%Strong Buy6-16.91%-30.32%61.30%13.73%
CORT
CORCEPT THERAPEUTICS INC
$2.48B$23.01$31.0034.72%Buy38.49%7.77%41.39%36.74%
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.48B$11.63$23.67103.50%Strong Buy3-39.18%N/A-7.39%-3.70%
BMRN
BIOMARIN PHARMACEUTICAL INC
$19.40B$104.39$110.465.81%Strong Buy1117.11%98.87%19.08%13.91%
EQRX
EQRX INC
$1.51B$3.10$4.1032.26%Hold4N/AN/A-23.38%-21.20%
VRTX
VERTEX PHARMACEUTICALS INC
$82.48B$321.32$308.85-3.88%Buy134.40%3.07%28.27%22.05%
VACC
VACCITECH PLC
$88.77M$2.38$19.33712.31%Strong Buy3-62.19%N/A-33.19%-29.38%
XRTX
XORTX THERAPEUTICS INC
$11.11M$0.86$11.001,186.55%Strong Buy1N/A72.93%N/AN/A
HALO
HALOZYME THERAPEUTICS INC
$7.82B$57.85$60.174.01%Strong Buy620.99%38.81%770.93%40.10%
EFTR
EFFECTOR THERAPEUTICS INC
$16.34M$0.39$7.401,797.44%Buy3N/AN/A-347.90%-109.73%
SELB
SELECTA BIOSCIENCES INC
$195.88M$1.28$5.33316.64%Buy3-50.59%N/A-41.45%-19.74%
BNTX
BIONTECH SE
$41.75B$171.81$214.2924.72%Buy8-40.11%-53.25%10.47%8.49%
AADI
AADI BIOSCIENCE INC
$323.72M$13.27$46.50250.41%Strong Buy232.16%N/A-43.85%-38.21%
AVIR
ATEA PHARMACEUTICALS INC
$383.96M$4.61$8.0073.54%Sell321.11%N/A0.63%0.61%
ABCL
ABCELLERA BIOLOGICS INC
$3.19B$11.14$26.40136.98%Strong Buy5N/AN/AN/AN/A
GRNA
GREENLIGHT BIOSCIENCES HOLDINGS PBC
$166.71M$1.10$4.75331.82%Strong Buy2N/AN/AN/AN/A
GNFT
GENFIT SA
$180.83M$3.63$9.00147.93%Buy214.27%N/A10.46%4.42%
MIRM
MIRUM PHARMACEUTICALS INC
$674.73M$18.30$60.75231.97%Strong Buy475.10%N/A81.89%38.05%
ALT
ALTIMMUNE INC
$508.80M$10.35$29.71187.09%Strong Buy7111.02%N/A-58.02%-52.81%
PTGX
PROTAGONIST THERAPEUTICS INC
$382.76M$7.78$29.75282.39%Strong Buy444.81%N/A-36.96%-31.91%
RGNX
REGENXBIO INC
$976.70M$22.56$41.5784.27%Buy7-20.63%N/A-37.86%-24.15%
LQDA
LIQUIDIA CORP
$365.04M$5.66$13.17132.63%Buy686.95%N/A20.36%14.60%
SEER
SEER INC
$407.80M$6.51$11.5076.65%Hold261.18%N/A-17.38%-15.90%
ZLAB
ZAI LAB LTD
$3.45B$35.23$100.33184.79%Strong Buy356.20%N/AN/AN/A
RVLP
RVL PHARMACEUTICALS PLC
$134.85M$1.36$3.50157.35%Buy360.79%N/A41.95%18.51%
CARA
CARA THERAPEUTICS INC
$657.16M$12.23$26.33115.31%Strong Buy385.39%N/A43.03%37.25%
LYRA
LYRA THERAPEUTICS INC
$94.84M$2.98$15.00403.36%Strong Buy170.59%N/A-85.01%-66.34%
FUSN
FUSION PHARMACEUTICALS INC
$107.43M$2.40$9.00275.00%Strong Buy5229.12%N/A-54.99%-42.23%
TBPH
THERAVANCE BIOPHARMA INC
$732.27M$10.87$14.3331.86%Hold314.68%N/A-4.91%-3.09%
CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
$5.41M$0.38$10.002,504.17%Strong Buy1213.60%N/A-40.18%-39.47%
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC
$477.93M$18.04$36.71103.51%Buy9111.91%N/A318.82%158.17%
KMPH
KEMPHARM INC
$159.41M$4.62$16.67260.76%Strong Buy352.92%N/A5.89%4.62%
BLU
BELLUS HEALTH INC
$1.25B$9.93$20.50106.45%Strong Buy431.68%N/A-34.75%-32.92%
RYTM
RHYTHM PHARMACEUTICALS INC
$1.49B$26.38$26.630.93%Strong Buy888.09%N/A-61.12%-44.11%
ABCM
ABCAM PLC
$3.55B$15.51$20.0028.95%Hold114.69%54.96%16.77%11.46%
TFFP
TFF PHARMACEUTICALS INC
$27.30M$1.07$18.001,582.24%Strong Buy1527.25%N/A223.71%199.33%
MRUS
MERUS NV
$617.68M$13.34$37.29179.51%Strong Buy734.90%N/A-40.45%-29.12%
ACIU
AC IMMUNE SA
$194.26M$2.30$10.00334.78%Buy1188.39%N/A-13.64%-12.61%
ETON
ETON PHARMACEUTICALS INC
$77.66M$3.07$10.00225.73%Buy144.05%N/A29.41%15.28%
ACET
ADICET BIO INC
$851.88M$19.88$25.8029.78%Strong Buy5-5.33%N/A-15.24%-13.67%
LXRX
LEXICON PHARMACEUTICALS INC
$409.53M$2.17$15.00591.24%Strong Buy2933.21%N/A30.14%22.64%
HSTO
HISTOGEN INC
$4.27M$1.00$1.5050.00%Buy180.97%N/A-113.72%-88.57%
IMAB
I-MAB
$325.46M$4.07$36.00784.52%Strong Buy3105.15%N/A-128.35%-103.27%
XENE
XENON PHARMACEUTICALS INC
$2.28B$36.53$48.8633.74%Strong Buy866.00%N/A-20.35%-19.75%
SESN
SESEN BIO INC
$105.23M$0.52$0.8054.14%Hold1-10.63%N/A0.00%0.00%
ICPT
INTERCEPT PHARMACEUTICALS INC
$608.83M$14.70$23.7561.56%Buy815.95%-58.13%271.56%52.27%
PGEN
PRECIGEN INC
$330.96M$1.59$9.00466.04%Strong Buy3-19.50%N/A-84.70%-46.57%
CASI
CASI PHARMACEUTICALS INC
$23.67M$1.74$10.00474.71%Strong Buy247.66%N/A37.04%17.87%
SNDX
SYNDAX PHARMACEUTICALS INC
$1.27B$21.07$32.3353.46%Strong Buy3-5.74%N/A-12.65%-11.89%
BNOX
BIONOMICS LIMITED
$53.06M$6.54$30.67369.27%Strong Buy3233.35%N/A-16,581.82%-14,449.79%
PALI
PALISADE BIO INC
$5.30M$3.44$5.0045.35%Buy2N/AN/A-1.74%-1.33%
CGEM
CULLINAN ONCOLOGY INC
$546.98M$11.95$32.67173.36%Strong Buy3N/AN/A-34.52%-32.78%
SPRC
SCISPARC LTD
$2.97M$0.96$20.001,983.33%Strong Buy1N/AN/A-154.15%-126.56%
ORTX
ORCHARD THERAPEUTICS PLC
$54.48M$0.43$4.00830.23%Buy240.93%N/A-27.65%-14.61%
JANX
JANUX THERAPEUTICS INC
$625.36M$15.01N/AN/ABuy1161.92%N/A-39.46%-34.82%
CBIO
CATALYST BIOSCIENCES INC
$16.41M$0.52N/AN/AStrong Buy3111.74%N/A-22.51%-21.32%
HCM
HUTCHMED (CHINA) LTD
$2.42B$14.00$16.0014.29%Hold130.11%N/A47.57%31.85%
RXRX
RECURSION PHARMACEUTICALS INC
$1.77B$9.34$12.6735.62%Buy448.98%N/A-68.88%-43.71%
VCNX
VACCINEX INC
$28.54M$0.67N/AN/AHold11,164.25%N/A831.66%610.13%
INMB
INMUNE BIO INC
$122.39M$6.82$10.5053.96%Buy2448.85%N/AN/AN/A
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
$90.91M$8.20$21.50162.20%Strong Buy1477.46%N/A130.35%115.08%
UPC
UNIVERSE PHARMACEUTICALS INC
$34.58M$1.59N/AN/AN/AN/AN/AN/AN/AN/A
DYAI
DYADIC INTERNATIONAL INC
$37.70M$1.32$6.00354.55%Buy281.30%N/A77.00%63.81%
OCUL
OCULAR THERAPEUTIX INC
$212.55M$2.76$16.00479.71%Strong Buy440.75%N/A18.32%5.34%
MRNS
MARINUS PHARMACEUTICALS INC
$157.34M$4.23$30.75626.95%Strong Buy440.18%N/A-0.91%-0.40%
VNDA
VANDA PHARMACEUTICALS INC
$612.87M$10.83$12.0010.80%Hold12.00%22.96%3.29%2.73%
CRSP
CRISPR THERAPEUTICS AG
$3.95B$50.50$87.3172.90%Buy16270.42%N/A11.74%9.75%
EDIT
EDITAS MEDICINE INC
$686.25M$9.98$17.8378.69%Hold1238.20%N/A-51.07%-39.88%
CLSD
CLEARSIDE BIOMEDICAL INC
$71.03M$1.18$7.25514.41%Strong Buy4-26.07%N/A-262.88%-87.55%
ARGX
ARGENX SE
$21.45B$389.52$436.4212.04%Strong Buy14256.32%N/A21.34%19.51%
SYBX
SYNLOGIC INC
$46.54M$0.66$7.671,061.67%Strong Buy3165.37%N/A-47.05%-36.84%
AGIO
AGIOS PHARMACEUTICALS INC
$1.58B$28.69$51.5079.51%Buy6151.76%N/A-21.97%-19.55%
FIXX
HOMOLOGY MEDICINES INC
$82.20M$1.43$9.58569.86%Strong Buy928.23%N/A-23.37%-18.60%
STTK
SHATTUCK LABS INC
$100.04M$2.36$18.50683.90%Strong Buy475.83%N/A-64.62%-57.80%
TCRT
ALAUNOS THERAPEUTICS INC
$145.49M$0.67$3.00345.77%Strong Buy2260.80%N/A-255.81%-121.98%
DBVT
DBV TECHNOLOGIES SA
$246.35M$1.31$7.50472.52%Buy274.79%N/A0.44%0.38%
DCPH
DECIPHERA PHARMACEUTICALS INC
$1.03B$15.24$20.3333.42%Hold617.86%N/A-13.20%-10.36%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Dec 2022?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Iteos Therapeutics (NASDAQ:ITOS)


Iteos Therapeutics (NASDAQ:ITOS) is the top biotech stock with a Zen Score of 66, which is 37 points higher than the biotech industry average of 29. It passed 21 out of 33 due diligence checks and has strong fundamentals. Iteos Therapeutics has seen its stock lose -41.57% over the past year, underperforming other biotech stocks by -4 percentage points.

Iteos Therapeutics has an average 1 year price target of $56.50, an upside of 178.33% from Iteos Therapeutics's current stock price of $20.30.

Iteos Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Iteos Therapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Moderna (NASDAQ:MRNA)


Moderna (NASDAQ:MRNA) is the second best biotech stock with a Zen Score of 64, which is 35 points higher than the biotech industry average of 29. It passed 21 out of 33 due diligence checks and has strong fundamentals. Moderna has seen its stock lose -34.83% over the past year, overperforming other biotech stocks by 2 percentage points.

Moderna has an average 1 year price target of $180.50, a downside of -2.27% from Moderna's current stock price of $184.70.

Moderna stock has a consensus Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Moderna, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Vir Biotechnology (NASDAQ:VIR)


Vir Biotechnology (NASDAQ:VIR) is the third best biotech stock with a Zen Score of 63, which is 34 points higher than the biotech industry average of 29. It passed 20 out of 33 due diligence checks and has strong fundamentals. Vir Biotechnology has seen its stock lose -38.41% over the past year, underperforming other biotech stocks by -1 percentage points.

Vir Biotechnology has an average 1 year price target of $49.60, an upside of 92.25% from Vir Biotechnology's current stock price of $25.80.

Vir Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 5 analysts covering Vir Biotechnology, 0% have issued a Strong Buy rating, 60% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 20% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 5.61%, which is 4 percentage points higher than the biotech industry average of 1.85%.

Siga Technologies's dividend payout ratio of 31% indicates that its high dividend yield is sustainable for the long-term.

2. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 1.66%, which is the same as the biotech industry average of 1.85%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 17.2% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.35%, which is -1 percentage points lower than the biotech industry average of 1.85%.

Royalty Pharma's dividend payout ratio of 64.9% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.26% in the last day, and down -1.26% over the last week. Pharvaris Nv was the among the top gainers in the biotechnology industry, gaining 356.57% yesterday.

Pharvaris shares are trading higher after the company reported top-line Phase 2 data from the RAPIDe-1 study of PHVS416 for the on-demand treatment of HAE attacks. The primary endpoint and all secondary endpoints were met.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Aptevo Therapeutics (NASDAQ:APVO)


Aptevo Therapeutics (NASDAQ:APVO) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Aptevo Therapeutics has a valuation score of 100, which is 65 points higher than the biotech industry average of 35. It passed 7 out of 7 valuation due diligence checks.

Aptevo Therapeutics's stock has dropped -60.23% in the past year. It has underperformed other stocks in the biotech industry by -23 percentage points.

2. Eqrx (NASDAQ:EQRX)


Eqrx (NASDAQ:EQRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Eqrx has a valuation score of 100, which is 65 points higher than the biotech industry average of 35. It passed 7 out of 7 valuation due diligence checks.

Eqrx's stock has dropped -68.88% in the past year. It has underperformed other stocks in the biotech industry by -32 percentage points.

3. Iteos Therapeutics (NASDAQ:ITOS)


Iteos Therapeutics (NASDAQ:ITOS) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Iteos Therapeutics has a valuation score of 100, which is 65 points higher than the biotech industry average of 35. It passed 7 out of 7 valuation due diligence checks.

Iteos Therapeutics's stock has dropped -41.57% in the past year. It has underperformed other stocks in the biotech industry by -4 percentage points.

Are biotech stocks a good buy now?

48.79% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 84.34% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 13.31x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.